Oddo BHF Asset Management Sas purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 25,445 shares of the company’s stock, valued at approximately $1,613,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. lifted its holdings in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after buying an additional 248 shares during the period. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Acadia Healthcare in the 2nd quarter valued at about $59,000. Covestor Ltd grew its stake in Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after purchasing an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale bought a new stake in Acadia Healthcare in the third quarter worth approximately $86,000.
Analyst Upgrades and Downgrades
Several analysts have recently commented on ACHC shares. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $45.00 to $75.00 in a research report on Thursday. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Royal Bank of Canada reduced their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday. Finally, Barclays reduced their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $75.44.
Acadia Healthcare Price Performance
Shares of NASDAQ:ACHC opened at $40.66 on Friday. Acadia Healthcare Company, Inc. has a 1-year low of $36.50 and a 1-year high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market cap of $3.78 billion, a PE ratio of 13.33, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The stock’s fifty day simple moving average is $45.39 and its two-hundred day simple moving average is $61.82.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the previous year, the company earned $0.91 earnings per share. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- What is a Stock Market Index and How Do You Use Them?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Stock Market Sectors: What Are They and How Many Are There?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Warren Buffett Stocks to Buy Now
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.